Table 3 |
|||||||
| Study characteristics | |||||||
| Study | Infusion of Mag | Treatment initiation of Mag | Route of Mag | Treatment Duration of Mag (hours) | Total dose of Mag (mmol) | Type of BBs | Definitions of AA with continuous ECG |
| Bert et al. [19] | Magnesium sulfate | Postop | Iv | 96 | 49 | Propranolol | POAT including AF, AFL, or a SVT that was sustained >5 minutes and warranted pharmacologic therapy |
| Cook et al. [22] | Magnesium sulfate | Preop | Iv | 120 | 102 | Atenolol | AA lasting >30 minutes or causing hemodynamic compromise requiring immediate intervention |
| Forlani et al. [20] | Magnesium sulfate | Preop | Iv | 144 | 37 | Sotalol | AF that required treatment for symptoms or hemodynamic deterioration |
| Geertman et al. [21] | Magnesium chloride | Preop | Iv | 36 | 75 | Sotalol | POAT including AF,AFL, and multifocal atrial tachycardia |
| Solomon et al. [23] | Magnesium sulfate | Postop | Iv | 24 | 73 | Propranolol | AF lasting longer than 1 hour or requiring therapy as a result of hemodynamic compromise |
Mag: magnesium; BBs: beta-blockers; Iv: intravenous; Preop: preoperatively; Postop: postoperatively; AA: atrial arrhythmias; POAT: postoperative atrial tachyarrhythmias; AF: atrial fibrillation; AFL: atrial flutter; SVT: supraventricular tachycardia.
Wu et al. BMC Cardiovascular Disorders 2013 13:5 doi:10.1186/1471-2261-13-5
